Your search returned 34 studies. (Get alerts for new studies):
- A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Conditions: Breast Cancer, - Advanced Solid Tumors, - Cowden Syndrome
8 Locations available
- Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies
Conditions: Leukemia - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Conditions: Solid Tumor - Hematological Malignancy
1 Location available
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphocytic, Acute, T-Cell - Juvenile Myelomonocytic Leukemia Lymphoblastic - T-cell Lymphoblastic Lymphoma - Myelodysplastic Syndrome
1 Location available
- A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ova
Conditions: Cancer - Carcinoma - Fallopian Tube Cancer - Gynecological Malignancies - Metastases - Oncology - Ovarian Cancer - Solid Tumors - Tumors
8 Locations available
- A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Conditions: Advanced Solid Tumors With FGFR1 Amplication, - Advanced Solid Tumors With FGFR2 Amplication, - Advanced Solid Tumors With FGFR3 Mutation
7 Locations available
- A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies
Conditions: Solid Tumors
1 Location available
- A Trial of RAD001 and Avastin in Children With Recurrent Solid Tumors
Conditions: Recurrent or Refractory Solid Tumors - CNS Malignancies
1 Location available
- Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Conditions: Advanced Solid Malignancies
3 Locations available
- Phase I Dose Escalation Trial Evaluating the Safety and Tolerability of AZD6244 and IMC-A12 in Subjects With Advanced Solid Malignancies
Conditions: Malignant Solid Tumour
1 Location available
- Safety Study of Live Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
Conditions: Solid Tumor Malignancies
2 Locations available
- Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Conditions: Breast Cancer
2 Locations available
- A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
Conditions: Advanced Solid Malignancies
3 Locations available
- A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
Conditions: Advanced Non-Hematologic Malignancies
4 Locations available
- Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Conditions: Cancer - Advanced Solid Malignancies
3 Locations available
- Use of Hydralzaine and Valproic Acid in Advanced Solid Tumor Malignancies
Conditions: Lung Cancer
1 Location available
- ABT-888 in Combo of LDFWAR to Treat Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis
Conditions: Advanced Solid Tumor With Peritoneal Carcinomatosis
1 Location available
- Lapatinib and Bortezomib in Patients With Advanced Malignancies
Conditions: Advanced Solid Tumors
1 Location available
- Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies
Conditions: Solid Malignancies
1 Location available
- MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
Conditions: Advanced Solid Tumors - Tumors - Cancer
1 Location available
- Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies
Conditions: Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Erlotinib in Combination With Pralatrexate in Advanced Malignancies
Conditions: Advanced Cancers - Solid Tumors
1 Location available
- Study to Assess Safety, Tolerability and PK of AZD1480 Alone or in Comb With Docetaxel in Patients With Solid Tumours
Conditions: Solid Malignancies
3 Locations available
- A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors
Conditions: Solid Tumor Malignancies
1 Location available
- A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
Conditions: Advanced Solid Tumors - With an Alteration of the PIK3CA Gene
4 Locations available
- Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies
Conditions: Bladder Cancer - Renal Pelvis Cancer - Ureter Cancer
1 Location available
- Study of Everolimus (RAD001)in Combination With Lenalidomide
Conditions: Solid Organ Malignancies
1 Location available
- Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
Conditions: NY-ESO-1 Positive Solid Tumors or Melanoma
2 Locations available
- Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Conditions: Advanced Malignancies - B-Cell Lymphoma - Solid Tumor
2 Locations available
- The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies
Conditions: Metastatic Solid Tumor - Lymphoma
1 Location available
- A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Conditions: CD27 Expressing B-cell Malignancies - CD27 Expressing Solid Tumors - Chronic Lymphocytic Leukemia - Burkett's Lymphoma - Mantle Cell Lymphoma - Primary Lymphoma of the Central Nervous System - Marginal Zone B Cell Lymphoma - Solid Tumor - Metastatic Melan
5 Locations available
- Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Conditions: Acute Lymphoid Leukemia - Acute Myeloid Leukemia - Chronic Lymphocytic Leukemia - Multiple Myeloma - Solid Tumors
18 Locations available
- Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
Conditions: Solid Malignancies - Metastatic Castrate-resistant Prostate Cancer
1 Location available
|